
ImmuCell
(NASDAQ) ICCC
ImmuCell Financials at a Glance
Market Cap
$65.05M
Revenue (TTM)
$27.64M
Net Income (TTM)
$1.04M
EPS (TTM)
$-0.11
P/E Ratio
-63.24
Dividend
$0.00
Beta (Volatility)
0.22 (Low)
Dividend
$0.00
Beta (Volatility)
0.22 (Low)
Price
$7.11
Volume
84,263.388
Open
$6.75
Price
$7.11
Volume
84,263.388
Open
$6.75
Previous Close
$7.19
Daily Range
$6.75 - $7.50
52-Week Range
$4.52 - $7.60
Dividend
$0.00
Beta (Volatility)
0.22 (Low)
Price
$7.11
Volume
84,263.388
Open
$6.75
Previous Close
$7.19
Daily Range
$6.75 - $7.50
52-Week Range
$4.52 - $7.60
ICCC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ImmuCell
Industry
Biotechnology
Sector
Health CareEmployees
73
CEO
Olivier te Boekhorst
Website
www.immucell.comHeadquarters
Portland, ME 04103, US
ICCC Financials
Key Financial Metrics (TTM)
Gross Margin
41%
Operating Margin
6%
Net Income Margin
-4%
Return on Equity
-4%
Return on Capital
4%
Return on Assets
-2%
Earnings Yield
-1.58%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$65.05M
Shares Outstanding
9.05M
Volume
84.26K
Short Interest
0.00%
Avg. Volume
17.09K
Financials (TTM)
Gross Profit
$11.45M
Operating Income
$1.65M
EBITDA
$4.43M
Operating Cash Flow
$2.48M
Capital Expenditure
$1.25M
Free Cash Flow
$1.22M
Cash & ST Invst.
$3.81M
Total Debt
$13.19M
ImmuCell Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.63M
-1.6%
Gross Profit
$2.91M
+2.8%
Gross Margin
38.16%
N/A
Market Cap
$65.05M
N/A
Market Cap/Employee
$942.70K
N/A
Employees
69
N/A
Net Income
$2.85M
-653.7%
EBITDA
$652.00K
-50.6%
Quarterly Fundamentals
Net Cash
$9.39M
+17.2%
Accounts Receivable
$3.42M
-10.3%
Inventory
$9.27M
+30.3%
Long Term Debt
$11.50M
-12.7%
Short Term Debt
$1.70M
-12.1%
Return on Assets
-2.44%
N/A
Return on Invested Capital
4.28%
N/A
Free Cash Flow
$914.62K
-359.0%
Operating Cash Flow
$1.99M
-65214.7%

